Life Healthcare Group Holdings Limited
LTGHFOTCHealthcare● Active
$0.72
$-0.09(-11.53%)
Market Cap$1.0B
P/E Ratio—
52W High$0.819
52W Low$0.6839
Life Healthcare Group Holdings Limited (LTGHF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
LTGHF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 28, 2026EPS Actual
$0.03
Revenue
$0.73B
Est. $0.73B · -0.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 28, 2026
After Market Close
✓ 1-Quarter EPS Beat Streak
LTGHF reports quarterly as a OTC-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2026 | Nov 26, 2026 | — | — | — | — | $0.80B | — |
| — Q2 FY2026 | May 28, 2026 | — | $0.03 | — | $0.73B | $0.73B | -0.0% |
| — Q2 FY2025 | May 20, 2025 | — | -$0.08 | — | $0.64B | $0.71B | -9.9% |
| — Q4 FY2024 | Nov 26, 2024 | — | $0.16 | — | $0.78B | $0.73B | +7.7% |
| — Q2 FY2024 | May 22, 2024 | — | $0.13 | — | $0.62B | $0.60B | +4.0% |
| — Q1 FY2024 | Feb 22, 2024 | — | -$0.01 | — | $0.38B | $0.85B | -54.6% |
| — Q1 FY2023 | Mar 31, 2023 | — | $0.02 | — | $0.85B | $0.82B | +4.0% |
| — Q3 FY2022 | Sep 30, 2022 | — | $0.04 | — | $0.81B | $0.79B | +2.3% |
Q4 FY2026
Nov 26, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 28, 2026
EPS Actual
$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.73B
Q2 FY2025
May 20, 2025
EPS Actual
-$0.08
EPS Est.
—
EPS Surpr.
—
Revenue
$0.64B
Q4 FY2024
Nov 26, 2024
EPS Actual
$0.16
EPS Est.
—
EPS Surpr.
—
Revenue
$0.78B
Q2 FY2024
May 22, 2024
EPS Actual
$0.13
EPS Est.
—
EPS Surpr.
—
Revenue
$0.62B
Q1 FY2024
Feb 22, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.38B
Q1 FY2023
Mar 31, 2023
EPS Actual
$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.85B
Q3 FY2022
Sep 30, 2022
EPS Actual
$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.81B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 28, 2026 | — | $0.82 | $0.82 | +0.00% |
| — Q2 FY2025 | May 20, 2025 | — | $0.82 | $0.82 | +0.00% |
| — Q4 FY2024 | Nov 26, 2024 | — | $0.54 | $0.54 | +0.00% |
| — Q2 FY2024 | May 22, 2024 | — | $0.54 | $0.54 | +0.00% |
| — Q1 FY2024 | Feb 22, 2024 | — | $1.00 | $1.00 | +0.00% |
| — Q1 FY2023 | Mar 31, 2023 | — | $1.02 | $1.02 | +0.00% |
| — Q3 FY2022 | Sep 30, 2022 | — | $1.02 | $1.02 | +0.00% |
| — Q1 FY2022 | Mar 31, 2022 | — | $1.41 | $1.41 | +0.00% |
Q2 FY2026+0.00%
Report Date
May 28, 2026
EPS Beat/Miss
—
Price Before
$0.82
Price After
$0.82
Q2 FY2025+0.00%
Report Date
May 20, 2025
EPS Beat/Miss
—
Price Before
$0.82
Price After
$0.82
Q4 FY2024+0.00%
Report Date
Nov 26, 2024
EPS Beat/Miss
—
Price Before
$0.54
Price After
$0.54
Q2 FY2024+0.00%
Report Date
May 22, 2024
EPS Beat/Miss
—
Price Before
$0.54
Price After
$0.54
Q1 FY2024+0.00%
Report Date
Feb 22, 2024
EPS Beat/Miss
—
Price Before
$1.00
Price After
$1.00
Q1 FY2023+0.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$1.02
Price After
$1.02
Q3 FY2022+0.00%
Report Date
Sep 30, 2022
EPS Beat/Miss
—
Price Before
$1.02
Price After
$1.02
Q1 FY2022+0.00%
Report Date
Mar 31, 2022
EPS Beat/Miss
—
Price Before
$1.41
Price After
$1.41
Beat Rate0 / 8 quarters
Largest Move+0.00% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: LTGHF ends December
Life Healthcare Group Holdings Limited (LTGHF) most recently reported earnings on May 28, 2026 for Q2 FY2026, posting EPS of $0.03 (in line with the analyst consensus of —). The next LTGHF earnings date is expected around September 1, 2026.
Each quarter, investors track LTGHF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LTGHF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
LTGHF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
LTGHF earnings · 4 questionsLife Healthcare Group Holdings Limited's next earnings report is expected around September 1, 2026. LTGHF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LTGHF historically reports after market close (AMC).
LTGHF earnings datewhen is LTGHF earningsLTGHF next earnings datewhen does LTGHF report earningsLTGHF earnings calendar
▸ Source: FMP · Life Healthcare Group Holdings Limited SEC filings · US GAAP · Life Healthcare Group Holdings Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026